Cardiac Fibroblast-Induced Pluripotent Stem Cell-Derived Exosomes as a Potential Therapeutic Mean for Heart Failure
Authors:
- Efrat Kurtzwald-JosefsonEKEfrat Kurtzwald-Josefson
- Naama Zeevi-LevinNZNaama Zeevi-Levin
- Victor RubchevskyVRVictor Rubchevsky
- Neta Bechar ErdmanNENeta Bechar Erdman
- Orna Schwartz RohakerOROrna Schwartz Rohaker
- Ortal NahumONOrtal Nahum
- Edith HochhauserEHEdith Hochhauser
- Ben Ben-AvrahamBBBen Ben-Avraham
- Joseph Itskovitz-EldorJIJoseph Itskovitz-Eldor
- Dan AravotDADan Aravot
- Yaron D. BaracYBYaron D. Barac
Open Access
- 29 September 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (19) , 7215
Abstract
The limited regenerative capacity of the injured myocardium leads to remodeling and often heart failure. Novel therapeutic approaches are essential. Induced pluripotent stem cells (iPSC) differentiated into cardiomyocytes are a potential future therapeutics. We hypothesized that organ-specific reprogramed fibroblasts may serve an advantageous source for future cardiomyocytes. Moreover, exosomes secreted from those cells may have a beneficial effect on cardiac differentiation and/or function. We compared RNA from different sources of human iPSC using chip gene expression. Protein expression was evaluated as well as exosome micro-RNA levels and their impact on embryoid bodies (EBs) differentiation. Statistical analysis identified 51 genes that were altered (p ≤ 0.05), and confirmed in the protein level, cardiac fibroblasts-iPSCs (CF-iPSCs) vs. dermal fibroblasts-iPSCs (DF-iPSCs). Several miRs were altered especially miR22, a key regulator of cardiac hypertrophy and remodeling. Lower expression of miR22 in CF-iPSCs vs. DF-iPSCs was observed. EBs treated with these exosomes exhibited more beating EBs p = 0.05. vs. control. We identify CF-iPSC and its exosomes as a potential source for cardiac recovery induction. The decrease in miR22 level points out that our CF-iPSC-exosomes are naïve of congestive heart cell memory, making them a potential biological source for future therapy for the injured heart.Keywords
Funding Information
- Israel Science Foundation (1929/12)
This publication has 44 references indexed in Scilit:
- Classification, Functions, and Clinical Relevance of Extracellular VesiclesPharmacological Reviews, 2012
- Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentationCell Death & Differentiation, 2012
- Arg/Abl‐binding protein, a Z‐body and Z‐band protein, binds sarcomeric, costameric, and signaling moleculesCytoskeleton, 2010
- Expression of GPR177 (Wntless/Evi/Sprinter), a highly conserved Wnt‐transport protein, in rat tissues, zebrafish embryos, and cultured human cellsDevelopmental Dynamics, 2010
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Heart repair and stem cellsThe Journal of Physiology, 2006
- The role of Wnt signalling in cardiac development and tissue remodelling in the mature heartCardiovascular Research, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Human muscle glutathione S-transferase (GST-4) shows close homology to human liver GST-1Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988